Literature DB >> 10487283

Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion.

H Ismail1, P Kaliciński, M Markiewicz, I Jankowska, J Pawłowska, P Kluge, E Eliadou, A Kamiński, M Szymczak, T Drewniak, Y Revillon.   

Abstract

Progressive intrahepatic familial cholestasis (PFIC), previously called Byler's disease, is a syndrome in which children develop severe cholestasis progressing to biliary cirrhosis and chronic liver failure, usually during the first decade of life. Clinical features include jaundice, hepatomegaly, splenomegaly, growth retardation and severe pruritus. Laboratory tests demonstrate elevated bilirubin and bile acids, without an increase in serum gamma-glutamyl-transpeptidase or cholesterol. This study was performed to evaluate our experience with medical therapy as well as two types of surgical treatment used in children with PFIC, particularly partial external biliary diversion (PEBD) as an alternative method of therapy to liver transplantation (OLTx). Between 1979 and 1998 we have treated 46 children with PFIC (27 boys and 19 girls), aged 10 months to 19 yr (at the time of this study). Medical treatment with ursodeoxycholic (UDCA) was used in 39 patients for the period between 6 and 82 months. PEBD (cholecysto-jejuno-cutaneostomy) was performed in 16 patients, OLTx in eight children (including one after unsuccessful PEBD). Retrospective analysis of the clinical course and selected laboratory tests (bilirubin, ASPAT, ALAT, bile acids), and histopathological examinations were performed. Results of treatment were assessed by means of influence of the type of treatment on clinical symptoms, laboratory tests, progress of liver cirrhosis and hepatic failure, as well as physical development and survival. Medical therapy was effective in the long term in four (10%) of the patients resulting in clinical and biochemical normalization. Both surgical methods of therapy of PFIC, PEBD and OLTx, resulted in an 80% success rate and therefore should be used as complementary therapies. In patients before established liver cirrhosis, PEBD should be the first choice of treatment. Patients presenting with cirrhosis or after ineffective PEBD should qualify for OLTx. With this strategy most children with PIFC can be cured.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487283     DOI: 10.1034/j.1399-3046.1999.00046.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  16 in total

Review 1.  Recent advances in pediatric liver transplantation.

Authors:  Debora Kogan-Liberman; Sukru Emre; Benjamin L Shneider
Journal:  Curr Gastroenterol Rep       Date:  2002-02

2.  Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Authors:  Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Karan Emerick; Anthony Antoniou; Catherine Wanty; Bjorn Fischler; Emmanuel Jacquemin; Sami Wali; Samra Blanchard; Inge-Merete Nielsen; Billy Bourke; Shirley McQuaid; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Leo Klomp; Roderick Houwen; Peter Bacchetti; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Benjamin Shneider; Antal Nemeth; Etienne Sokal; Nelson B Freimer; A S Knisely; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson; Laura N Bull
Journal:  J Hepatol       Date:  2010-04-13       Impact factor: 25.083

3.  An outstanding non-transplant surgical intervention in progressive familial intrahepatic cholestasis: partial internal biliary diversion.

Authors:  F Gün; B Erginel; O Durmaz; S Sökücü; T Salman; A Celik
Journal:  Pediatr Surg Int       Date:  2010-06-20       Impact factor: 1.827

Review 4.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

5.  Outcome of partial internal biliary diversion for intractable pruritus in children with cholestatic liver disease.

Authors:  P Ramachandran; N P Shanmugam; S Al Sinani; V Shanmugam; S Srinivas; M Sathiyasekaran; V Tamilvanan; M Rela
Journal:  Pediatr Surg Int       Date:  2014-07-27       Impact factor: 1.827

6.  Orthotopic liver transplantation in a pediatric patient with progressive intrahepatic cholestasis: a coordinated perioperative subspecialty approach.

Authors:  Donald R Ganier; Jimmie E Colón
Journal:  Ochsner J       Date:  2011

Review 7.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

8.  Living-donor liver transplantation for progressive familial intrahepatic cholestasis.

Authors:  Tomohide Hori; Hiroto Egawa; Aya Miyagawa-Hayashino; Tohru Yorifuji; Yukihide Yonekawa; Justin H Nguyen; Shinji Uemoto
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

Review 9.  Partial external biliary diversion for the treatment of intractable pruritus in children with progressive familial intrahepatic cholestasis: report of two cases.

Authors:  Saniye Ekinci; Ibrahim Karnak; Figen Gürakan; Aysel Yüce; Mehmet Emin Senocak; F Cahit Tanyel; Nebil Büyükpamukçu
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

Review 10.  Congenital cholestatic syndromes: what happens when children grow up?

Authors:  S C Ling
Journal:  Can J Gastroenterol       Date:  2007-11       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.